Contact
Please use this form to send email to PR contact of this press release:
OncoMed Doses First Patient with GITRL-Fc in Phase 1a Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
OncoMed Doses First Patient with GITRL-Fc in Phase 1a Clinical Trial
TO: